Table Of Content

European Journal of Pharmacology 278 (1995) 285—287 Author index Acri, J.B., Wong, G. and Witkin, J.M. De Bigontina, P., see Giamberardino, M.A. (278) 97 Stereospecific transduction of behavioral effects via diazepam-in- De Castiglione, R., see Miasiro, N. (278) 103 sensitive GABA, receptors (278) 213 Del Tacca, M., see Blandizzi, C. (278) 179 Advenier, C., see Molimard, M. (278) 49 De Souza, E.B., see Levant, B. (278) 243 Advenier, C., see Molimard, M. (278) 253 Doods, H.N., see Entzeroth, M. (278) 239 Akiyama, K., see Sutoo, D. (278) 33 Dooley, D.J., see Wessler, I. (278) 83 Allen, J., see Le Rouzic, M. (278) 261 Dumont, Y., see Jacques, D. (278) R3 Altier, H., see Ponzoni, A. (278) 111 Andrews, P.L.R., see Woods, A.J. (278) 275 Eberlein, W., see Entzeroth, M. (278) 239 Angel, I., see Le Rouzic, M. (278) 261 Eglen, R.M., see Watson, N. (278) 195 Araki, T., Kato, H., Fujiwara, T., Kogure, K. and Itoyama, Y. Engel, W., see Entzeroth, M. (278) 239 Post-ischemic changes of [*H]glycine binding in the gerbil brain Entzeroth, M., Braunger, H., Eberlein, W., Engel, W., Rudolf, K.., after cerebral ischemia (278) 91 Wienen, W., Wieland, H.A., Willim, K.-D. and Doods, H.N. Arbilla, S., see Le Rouzic, M. (278) 261 Labeling of neuropeptide Y receptors in SK-N-MC cells using the novel, nonpeptide Y, receptor-selective antagonist [*H]- Bartho, L., see Patacchini, R. (278) 17 BIBP3226 (278) 239 Bascands, J.-L., see Bompart, G. (278) 225 Bertha, C.M., see Bowen, W.D. (278) 257 Frey, K., see Kilbourn, M. (278) 249 Bielanski, W., see Konturek, S.J. (278) 203 Fujiwara, T., see Araki, T. (278) 91 Blandizzi, C., Natale, G., Colucci, R., Carignani, D., Lazzeri, G. and Del Tacca, M. Galligan, J.J., see Pan, H. (278) 67 Characterization of a@,-adrenoceptor subtypes involved in the Garfield, R.E., see Izumi, H. (278) 187 modulation of gastric acid secretion (278) 179 Giamberardino, M.A., Valente, R., De Bigontina, P., lezzi, S. and Bompart, G., Tack, I., Bascands, J.-L. and Girolami, J.-P. Vecchiet, L. Intracellular Ca2* depletion and Ca?* channel blockers increase Effects of spasmolytic and/or non-steroidal antiinflammatory renal kallikrein secretion (278) 225 drugs on muscle hyperalgesia of ureteral origin in rats (278) 97 Bowe, M.A. and Nadler, J.V. Gibb, J.W., see Hanson, G.R. (278) 167 Polyamines antagonize N-methyl-p-aspartate-evoked depolariza- Girolami, J.-P., see Bompart, G. (278) 225 tions, but reduce Mg’* block (278) 55 Grigoriadis, D.E., see Levant, B. (278) 243 Bowen, W.D., Bertha, C.M., Vilner, B.J. and Rice, K.C. CB-64D and CB-184: ligands with high o, receptor affinity and Hammer, Jr., R.P., see Zhou, L. (278) 271 subtype selectivity (278) 257 Hanson, G.R., Midgley, L.P., Bush, L.G. and Gibb, J.W. Braunger, H., see Entzeroth, M. (278) 239 Response of extrapyramidal and limbic neurotensin systems to Brent, P.J. and Pang, G.T. phencyclidine treatment (278) 167 o Binding site ligands inhibit cell proliferation in mammary and Heinemann, A. and Stauber, R.E. colon carcinoma cell lines and melanoma cells in culture (278) The role of inducible nitric oxide synthase in vascular hyporeac- 151 tivity of endotoxin-treated and portal hypertensive rats (278) 87 Brzozowski, T., see Konturek, S.J. (278) 203 Hirsch, A., see Molimard, M. (278) 49 Budai, D., Wilcox, G.L. and Larson, A.A. Hirsch, A., see Molimard, M. (278) 253 Effects of nitric oxide availability on responses of spinal wide Holzer, P., see Patacchini, R. (278) 17 dynamic range neurons to excitatory amino acids (278) 39 Bush, L.G., see Hanson, G.R. (278) 167 lezzi, S., see Giamberardino, M.A. (278) 97 Byam-Smith, M., see Izumi, H. (278) 187 Itoyama, Y., see Araki, T. (278) 91 Izumi, H., Byam-Smith, M. and Garfield, R.E. Cadieux, A., see Jacques, D. (278) R3 Gestational changes in oxytocin- and endothelin-l-induced con- Carignani, D., see Blandizzi, C. (278) 179 tractility of pregnant rat myometrium (278) 187 Carlsson, A., see Kujacic, M. (278) 9 Chiba, Y. and Misawa, M. Jacques, D., Cadieux, A., Dumont, Y. and Quirion, R. Alteration in Ca?* availability involved in antigen-induced airway Apparent affinity and potency of BIBP3226, a non-peptide neu- hyperresponsiveness in rats (278) 79 ropeptide Y receptor antagonist, on purported neuropeptide Y Chiu, T.H., see Wu, Y. (278) 125 Y,, Y, and Y, receptors (278) R3 Colucci, R., see Blandizzi, C. (278) 179 Jantos, H., see Ponzoni, A. (278) 111 Conte, B., see Parlani, M. (278) 117 Jewett, D., see Kilbourn, M. (278) 249 Corbett, R., see Roehr, J. (278) 75 Jones, R.L., see Wise, H. (278) 265 286 Author index Kato, H., see Araki, T. (278) 91 Naline, E., see Molimard, M. (278) 49 Katsumata, S., Minami, M., Nakagawa, T. and Satoh, M. Natale, G., see Blandizzi, C. (278) 179 Intracisternal administration of interleukin-18 attenuates nalox- Nunes, J.P. one-precipitated withdrawal in morphine-dependent mice (278) Central aj-adrenoceptors and blood pressure regulation in the 143 rat (278) 183 Kellar, K.J., see London, E.D. (278) R1 Keuskamp, Z.J., see Van Dijk, J.P.M. (278) R11 Paiva, A.C.M., see Miasiro, N. (278) 103 Kilbourn, M., Lee, L., Vander Borght, T., Jewett, D. and Frey, K. Pan, H. and Galligan, J.J. Binding of a-dihydrotetrabenazine to the vesicular monoamine Effects of S-HT,, and 5-HT, receptor agonists on slow synaptic transporter is stereospecific (278) 249 potentials in enteric neurons (278) 67 Kimes, A.S., see London, E.D. (278) R1 Pang, G.T., see Brent, P.J. (278) 151 Kogure, K., see Araki, T. (278) 91 Parfenova, H. and Leffler, C.W. Kongsamut, S., see Roehr, J. (278) 75 Functional study on vasodilator effects of prostaglandin E, in the Konno, K., see Tamaoki, J. (278) 161 newborn pig cerebral circulation (278) 133 Konturek, S.J., Brzozowski, T., Bielanski, W. and Schally, A.V. Parlani, M., Conte, B. and Manzini, S. Role of endogenous gastrin in gastroprotection (278) 203 Opposite modulation by tachykinin (NK,) and CGRP receptors Kujacic, M. and Carlsson, A. of sympathetic control of mouse vas deferens motility (278) 117 In vivo activity of tyrosine hydroxylase in rat adrenal glands Patacchini, R., Bartho, L., Holzer, P. and Maggi, C.A. following administration of quinpirole and dopamine (278) 9 Activity of SR 142801 at peripheral tachykinin receptors (278) 17 Kunos, G., see Varga, K. (278) 279 Ponzoni, A., Monti, J.M., Jantos, H., Altier, H. and Monti, D. Increased waking after intra-accumbens injection of m-chloro- Lake, K., see Varga, K. (278) 279 phenylbiguanide: prevention with serotonin or dopamine recep- Langer, S.Z., see Le Rouzic, M. (278) 261 tor antagonists (278) 111 Larson, A.A., see Budai, D. (278) 39 Qian, Y.-m., see Wise, H. (278) 265 Lazzeri, G., see Blandizzi, C. (278) 179 Quirion, R., see Jacques, D. (278) R3 Lee, L., see Kilbourn, M. (278) 249 Leffler, C.W., see Parfenova, H. (278) 133 Rao, M.-R., see Xu, Y. (278) 1 Le Rouzic, M., Angel, I., Schoemaker, H., Allen, J., Arbilla, S. and Reddy, H., see Watson, N. (278) 195 Langer, S.Z. Rice, K.C., see Bowen, W.D. (278) 257 Binding of [*H]cirazoline to an imidazoline site in rat brain and Roehr, J., Woods, A., Corbett, R. and Kongsamut, S. kidney membranes (278) 261 Changes in paroxetine binding in the cerebral cortex of polydipsic Levant, B., Grigoriadis, D.E. and De Souza, E.B. rats (278) 75 Relative affinities of dopaminergic drugs at dopamine D, and D, Rosenberg, H.C., see Wu, Y. (278) 125 receptors (278) 243 Rudolf, K., see Entzeroth, M. (278) 239 Liu, C.-F., see Tao, P.-L. (278) 233 Lohr, B., see Wessler, I. (278) 83 Sakai, A., see Tamaoki, J. (278) 161 London, E.D., Scheffel, U., Kimes, A.S. and Kellar, K.J. Satoh, M., see Katsumata, S. (278) 143 In vivo labeling of nicotinic acetylcholine receptors in brain with Schally, A.V., see Konturek, S.J. (278) 203 [*H]epibatidine (278) R1 Scheffel, U., see London, E.D. (278) R1 Lopez-Belmonte, J. and Whittle, B.J.R. Schoemaker, H., see Le Rouzic, M. (278) 261 Endothelin-1 induces neutrophil-independent vascular injury in Sim, M.K. and Yuan, H.T. the rat gastric microcirculation (278) R7 Effects of des-Asp-angiotensin I on the contractile action of angiotensin II and angiotensin III (278) 175 Madretsma, G.S., see Van Dijk, J.P.M. (278) R11 Stauber, R.E., see Heinemann, A. (278) 87 Maggi, C.A., see Patacchini, R. (278) 17 Sutoo, D., Akiyama, K. and Takita, H. Manzini, S., see Parlani, M. (278) 117 Hypertension in epileptic mice: a phenomenon related to reduc- Martin, B.R., see Varga, K. (278) 279 tion of Ca?*-dependent catecholamine synthesis in the brain Martin, C.A.E., see Molimard, M. (278) 49 (278) 33 Miasiro, N., De Castiglione, R. and Paiva, A.C.M. Role of positions 9 and 10 in the endothelin molecule for biologi- Tack, IL., see Bompart, G. (278) 225 cal activity and discrimination of receptor subtypes (278) 103 Tagaya, E., see Tamaoki, J. (278) 161 Midgley, L.P., see Hanson, G.R. (278) 167 Takemura, H., see Tamaoki, J. (278) 161 Minami, M., see Katsumata, S. (278) 143 Takita, H., see Sutoo, D. (278) 33 Misawa, M., see Chiba, Y. (278) 79 Tamaoki, J., Takemura, H., Tagaya, E., Sakai, A., Yamawaki, I. and Molimard, M., Martin, C.A.E., Naline, E., Hirsch, A. and Advenier, Konno, K. 2d Effect of azelastine on airway hyperresponsiveness mediated by Role of thromboxane A, in bradykinin-induced human isolated stimulated macrophages (278) 161 small bronchi contraction (278) 49 Tao, P.-L., Liu, C.-F. and Tsai, H.-C. Molimard, M., Naline, E., Hirsch, A. and Advenier, C. Chronic intracerebroventricular administration of morphine Furosemide inhibits bradykinin-induced contraction of human down-regulates spinal adenosine A, receptors in rats (278) 233 bronchi: role of thromboxane A, receptor antagonism (278) 253 Tripathi, A. and Welch, S.P. Monti, D., see Ponzoni, A. (278) 111 Blockade of the antinociceptive activity of centrally administered Monti, J.M., see Ponzoni, A. (278) 111 ketorolac by nor-binaltorphimine (278) 27 Tsai, H.-C., see Tao, P.-L. (278) 233 Nadler, J.V., see Bowe, M.A. (278) 55 Nakagawa, T., see Katsumata, S. (278) 143 Valente, R., see Giamberardino, M.A. (278) 97 Naline, E., see Molimard, M. (278) 253 Vander Borght, T., see Kilbourn, M. (278) 249 Author index Van Dijk, J.P.M., Madretsma, G.S., Keuskamp, Z.J. and Zijlstra, F.J. Witkin, J.M., see Acri, J.B. (278) 213 Nicotine inhibits cytokine synthesis by mouse colonic mucosa Wong, G., see Acri, J.B. (278) 213 (278) R11 Woods, A., see Roehr, J. (278) 75 Varga, K., Lake, K., Martin, B.R. and Kunos, G. Woods, A.J. and Andrews, P.L.R. Novel antagonist implicates the CB, cannabinoid receptor in the Cisplatin acutely reduces 5-hydroxytryptamine-induced vagal de- hypotensive action of anandamide (278) 279 polarization in the rat: protective action of dexamethasone (278) Vecchiet, L., see Giamberardino, M.A. (278) 97 275 Vilner, B.J., see Bowen, W.D. (278) 257 Wu, Y., Rosenberg, H.C. and Chiu, T.H. Rapid down-regulation of [*H]zolpidem binding to rat brain Watson, N., Reddy, H. and Eglen, R.M. benzodiazepine receptors during flurazepam treatment (278) 125 Role of muscarinic M, and M, receptors in guinea-pig trachea: effects of receptor alkylation (278) 195 Xu, Y. and Rao, M.-R. Welch, S.P., see Tripathi, A. (278) 27 Effects of tetrandrine on left ventricle hypertrophy in deoxycorti- Wessler, I., Dooley, D.J. and Lohr, B. P-type Ca** channels trigger stimulus-evoked [*H]acetylcholine costerone acetate-salt hyperténsive rats (278) 1 release from mammalian motor endplates (278) 83 Whittle, B.J.R., see Lopez-Belmonte, J. (278) R7 Yamawaki, I., see Tamaoki, J. (278) 161 Wieland, H.A., see Entzeroth, M. (278) 239 Yuan, H.T., see Sim, M.K. (278) 175 Wienen, W., see Entzeroth, M. (278) 239 Wilcox, G.L., see Budai, D. (278) 39 Willim, K.-D., see Entzeroth, M. (278) 239 Zhou, L. and Hammer, Jr., R.P. Wise, H., Qian, Y.-m. and Jones, R.L. Gonadal steroid hormones upregulate medial preoptic p-opioid A study of prostacyclin mimetics distinguishes neuronal from receptors in the rat (278) 271 neutrophil IP receptors (278) 265 Zijlstra, F.J., see Van Dijk, J.P.M. (278) R11